Registered Nurse in Kingston, TN Accepting Medicare

6 Registered Nurse nurses found. Showing 1 - 6

Maleah Victoria Washam, Registered Nurse - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1114 Fairgrounds Ct, Kingston, TN 37763 Phone: 865-919-4783    Fax: 865-674-4422

Loretta Rose Turbeville, RN, MSN, FNP-C Registered Nurse - General Practice Medicare: Medicare Enrolled Practice Location: 112 Victoria Rd, Kingston, TN 37763 Phone: 865-809-2033    Fax: 888-657-5448

Judy Hargis, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 161 Woods Ln, Kingston, TN 37763 Phone: 865-333-9751

Rosza Branson, Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 1202 Laurel Bluff Rd, Kingston, TN 37763 Phone: 865-742-4935

Denise Lynne Willer, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 629 Gallaher Rd, Kingston, TN 37763 Phone: 865-376-3416

Tracey Keathley, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 114 Lakewood Ldg, Kingston, TN 37763 Phone: 865-617-5039    Fax: 865-315-7232

News Archive

Aeterna Zentaris to present poster on AEZS-130 growth hormone secretagogue/ghrelin receptor agonist at 92nd ENDO

Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, will be presented at the upcoming 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which will be held June 19 through 22, 2010 at the San Diego Convention Center in San Diego, California.

Marginalized populations should be focus of HIV prevention efforts, opinion piece says

Although the U.S. has "relatively abundant resources available to those living with HIV," socioeconomic gaps continue to lead to higher rates of the virus among marginalized groups in the country, Christine Jolly, president of AIDS Care Service, writes in a Winston-Salem Journal opinion piece.

Pfizer to present new investigational compounds data against cancer at AACR meeting

Pfizer Oncology will present nearly 30 abstracts highlighting research in new and established pathways, including inhibition of Hedgehog signaling; dual inhibition of PI3K/mTOR; and cancer stem cell-based targets.

Positive data from Æterna Zentaris' Phase 2 targeted cytotoxic peptide conjugate study

Æterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with advanced or recurrent endometrial cancer.

Read more Medical News

› Verified 1 days ago